Hot Melt Extrusion-Triggered Amorphization as a Continuous Process for Inducing Extended Supersaturable Drug Immediate-Release from saSMSDs Systems

Hot melt extrusion (HME), a continuous manufacturing process for generating supersaturating amorphous self-micellizing solid dispersion systems (saSMSDs), holds promise for achieving amorphization of many pharmaceutical formulations. For saSMSDs generation, HME-triggered continuous processes offer a...

Full description

Saved in:
Bibliographic Details
Main Authors: Huan Yu (Author), Yanfei Zhang (Author), Yinghui Ma (Author), Huifeng Zhang (Author), Chengyi Hao (Author), Yong Zhang (Author), Zhengqiang Li (Author), Xianrong Qi (Author), Nianqiu Shi (Author)
Format: Book
Published: MDPI AG, 2022-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_856a6ad8d1b94e3da8eece06e7d5a062
042 |a dc 
100 1 0 |a Huan Yu  |e author 
700 1 0 |a Yanfei Zhang  |e author 
700 1 0 |a Yinghui Ma  |e author 
700 1 0 |a Huifeng Zhang  |e author 
700 1 0 |a Chengyi Hao  |e author 
700 1 0 |a Yong Zhang  |e author 
700 1 0 |a Zhengqiang Li  |e author 
700 1 0 |a Xianrong Qi  |e author 
700 1 0 |a Nianqiu Shi  |e author 
245 0 0 |a Hot Melt Extrusion-Triggered Amorphization as a Continuous Process for Inducing Extended Supersaturable Drug Immediate-Release from saSMSDs Systems 
260 |b MDPI AG,   |c 2022-03-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics14040765 
500 |a 1999-4923 
520 |a Hot melt extrusion (HME), a continuous manufacturing process for generating supersaturating amorphous self-micellizing solid dispersion systems (saSMSDs), holds promise for achieving amorphization of many pharmaceutical formulations. For saSMSDs generation, HME-triggered continuous processes offer advantages over traditional non-continuous processes such as fusion/quench cooling (FQC) and co-precipitation (CP). Here we employed HME, FQC, and CP to generate saSMSDs containing the water-insoluble BCS II drug nitrendipine (NIT) and self-micellizing polymer Soluplus<sup>®</sup>. Scanning electron microscopy, powder X-ray diffraction, and differential scanning calorimetry results revealed that saSMSDs formed when NIT-Soluplus<sup>®</sup> mixtures were subjected to the abovementioned amorphization methods. All saSMSDs outperformed crystalline NIT preparations and physical mixtures in achieving extended supersaturable immediate release states with superior solubility, "spring-parachute" process characteristics, and dissolution behaviors. Notably, Fourier transform-infrared spectroscopic results obtained for saSMSDs detected hydrogen bonding interactions between the drug and the carrier. Ultimately, our results revealed the advantages of HME-triggered amorphization as a continuous process for significantly improving drug dissolution, increasing solubility, and maintaining supersaturation as compared to traditional amorphization-based techniques. 
546 |a EN 
690 |a hot melt extrusion (HME)-triggered amorphization 
690 |a continuous manufacturing process 
690 |a supersaturating amorphous self-micellizing solid dispersions (saSMSDs) 
690 |a extended supersaturable immediate release 
690 |a "spring-parachute" processes 
690 |a crystallization inhibition and stabilization of amorphism 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 14, Iss 4, p 765 (2022) 
787 0 |n https://www.mdpi.com/1999-4923/14/4/765 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/856a6ad8d1b94e3da8eece06e7d5a062  |z Connect to this object online.